Evidence map›Paper›PMID 37331983›Full record

Trial reportJournal of the International Society of Sports Nutrition2023

Effects of fucoidan supplementation on inflammatory and immune response after high-intensity exercise.

Bridget A McFadden, Caroline S Vincenty, Alexa J Chandler, Harry P Cintineo, Blaine S Lints, Gianna F Mastrofini, Shawn M Arent

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the International Society of Sports Nutrition, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Fucoidan fromResearch and reports in urology · 2026
    Trial
  5. Trial
  6. Review
  7. Review
  8. Review
  9. Review
  10. Nasal Administration ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Fucoidan fromMarine drugs · 2024
    Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bridget A McFaddenUniversity of South Carolina, Department of Exercise Science, Columbia, SC, USA.ORCID 0000-0002-8626-9531
Caroline S VincentyUniversity of South Carolina, Department of Exercise Science, Columbia, SC, USA.
Alexa J ChandlerUniversity of South Carolina, Department of Exercise Science, Columbia, SC, USA.ORCID 0000-0002-8726-1646
Harry P CintineoUniversity of South Carolina, Department of Exercise Science, Columbia, SC, USA.ORCID 0000-0002-8707-1842
Blaine S LintsUniversity of South Carolina, Department of Exercise Science, Columbia, SC, USA.
Gianna F MastrofiniUniversity of South Carolina, Department of Exercise Science, Columbia, SC, USA.
Shawn M ArentUniversity of South Carolina, Department of Exercise Science, Columbia, SC, USA.ORCID 0000-0003-0647-0591

Funding

Biomedical-Behavioral Interface: Prevention and Developmental Sciences TrainingT32GM081740 · NIGMS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI PRINZ, RONALD J · 2008 to 2022
$4.5M
NIGMS NIH HHS T32 GM081740
6 · The paper itself

Abstract

introductionHigh-intensity exercise (HIE) can damage the musculotendon complex and impact the immune response, resulting in post-exercise inflammation. Sufficient rest and recovery will improve muscular resilience against future damaging bouts; however, HIE with minimal durations of rest is common in athletic competitions that facilitate persistent inflammation and immune dysregulation. Fucoidans are fucose-rich sulfated polysaccharides with demonstrated anti-inflammatory and pro-immune responses. Fucoidans may improve inflammation and immune responses, which may prove beneficial for individuals who regularly engage in repeated HIE. The research purpose was to investigate the safety and efficacy of fucoidans on inflammatory and immune markers following HIE.

methodsEight male and eight female participants were randomized into a double-blind, placebo-controlled, counterbalanced, crossover design study and supplemented with 1 g/day fucoidan from

resultsA time-by-condition interaction was observed for interleukin-6 ( DISCUSSION: No adverse events were reported throughout the study period, indicating a positive safety profile of UPF. While notable changes in biomarkers occurred up to 1 hr post HIE, few differences were observed between supplementation conditions. There did appear to be a modest effect of UPF on inflammatory cytokines potentially warranting further investigation. However, fucoidan supplementation did not influence exercise performance.

Indexed as

Interleukin-10Interleukin-6Dietary SupplementsDouble-Blind MethodFemaleHumansInflammationMalePolysaccharidesfucoidanInterleukin-10Interleukin-6PolysaccharidescytokinesMarine algae supplementpeak powerrecovery

Identifiers

PMID37331983
PMCPMC10281294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.